Search Results - "Journal of thrombosis and thrombolysis"

Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2 by Yin, Shiyu, Huang, Ming, Li, Dengju, Tang, Ning

“…Severe coronavirus disease 2019 (COVID-19) is commonly complicated with coagulopathy, the difference of coagulation features between severe pneumonia induced…”
Get full text

Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum by Barnes, Geoffrey D., Burnett, Allison, Allen, Arthur, Blumenstein, Marilyn, Clark, Nathan P., Cuker, Adam, Dager, William E., Deitelzweig, Steven B., Ellsworth, Stacy, Garcia, David, Kaatz, Scott, Minichiello, Tracy

“…Coronavirus disease 2019 (COVID-19) is a viral infection that can, in severe cases, result in cytokine storm, systemic inflammatory response and coagulopathy…”
Get full text

Neutrophil extracellular traps and thrombosis in COVID-19 by Zuo, Yu, Zuo, Melanie, Yalavarthi, Srilakshmi, Gockman, Kelsey, Madison, Jacqueline A., Shi, Hui, Woodard, Wrenn, Lezak, Sean P., Lugogo, Njira L., Knight, Jason S., Kanthi, Yogendra

“…Studies of patients with COVID-19 have demonstrated markedly dysregulated coagulation and a high risk of morbid arterial and venous thrombotic events. Elevated…”
Get full text

COVID-19-associated vasculitis and vasculopathy by Becker, Richard C.

“…The COVID-19 pandemic now totaling 13,000,000 cases and over 571,000 deaths has continued to teach the medical, scientific and lay communities about viral…”
Get full text

COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature by Tan, Ying-Kiat, Goh, Claire, Leow, Aloysius S. T., Tambyah, Paul A., Ang, Alicia, Yap, Eng-Soo, Tu, Tian-Ming, Sharma, Vijay K., Yeo, Leonard L. L., Chan, Bernard P. L., Tan, Benjamin Y. Q.

“…Acute ischemic stroke (AIS) is a life-threatening complication of coronavirus disease 2019 (COVID-19) infection. Increasing reports suggest an association…”
Get full text

Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors by Artifoni, Mathieu, Danic, Gwenvael, Gautier, Giovanni, Gicquel, Pascal, Boutoille, David, Raffi, François, Néel, Antoine, Lecomte, Raphaël

“…Coagulopathy in COVID-19 is a burning issue and strategies to prevent thromboembolic events are debated and highly heterogeneous. The objective was to…”
Get full text

The epidemiology of venous thromboembolism by Heit, John A., Spencer, Frederick A., White, Richard H.

“…Venous thromboembolism (VTE) is categorized by the U.S. Surgeon General as a major public health problem. VTE is relatively common and associated with reduced…”
Get full text

Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia by Pavoni, Vittorio, Gianesello, Lara, Pazzi, Maddalena, Stera, Caterina, Meconi, Tommaso, Frigieri, Francesca Covani

“…Critically ill patients with COVID-19 pneumonia suffered both high thrombotic and bleeding risk. The effect of SARS-CoV-2 on coagulation and fibrinolysis is…”
Get full text

Heparin resistance in COVID-19 patients in the intensive care unit by White, D., MacDonald, S., Bull, T., Hayman, M., de Monteverde-Robb, R., Sapsford, D., Lavinio, A., Varley, J., Johnston, A., Besser, M., Thomas, W.

“…Patients with COVID-19 have a coagulopathy and high thrombotic risk. In a cohort of 69 intensive care unit (ICU) patients we investigated for evidence of…”
Get full text

The association between treatment with heparin and survival in patients with Covid-19 by Ayerbe, Luis, Risco, Carlos, Ayis, Salma

“…This study investigates the association between the treatment with heparin and mortality in patients admitted with Covid-19. Routinely recorded, clinical data,…”
Get full text

Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis by Yu, Bilian, Li, Xin, Chen, Jin, Ouyang, Mingqi, Zhang, Hong, Zhao, Xinge, Tang, Liang, Luo, Qin, Xu, Min, Yang, Lizhen, Huang, Guxiang, Liu, Xianling, Tang, Jianjun

“…In the recent outbreak of novel coronavirus infection worldwide, the risk of thrombosis and bleeding should be concerned. We aimed to observe the dynamic…”
Get full text

Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients by Zhang, Yan, Cao, Wei, Jiang, Wei, Xiao, Meng, Li, Yongzhe, Tang, Ning, Liu, Zhengyin, Yan, Xiaowei, Zhao, Yongqiang, Li, Taisheng, Zhu, Tienan

“…The outbreak of novel coronavirus disease 2019 (COVID-19) has now become a global pandemic. Coagulopathy has been reported widely in critically ill COVID-19…”
Get full text

Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment by Burnett, Allison E., Mahan, Charles E., Vazquez, Sara R., Oertel, Lynn B., Garcia, David A., Ansell, Jack

“…Venous thromboembolism (VTE) is a serious medical condition associated with significant morbidity and mortality, and an incidence that is expected to double in…”
Get full text

Guidance for the treatment and prevention of obstetric-associated venous thromboembolism by Bates, Shannon M., Middeldorp, Saskia, Rodger, Marc, James, Andra H., Greer, Ian

“…Venous thromboembolism (VTE), which may manifest as pulmonary embolism (PE) or deep vein thrombosis (DVT), is a serious and potentially fatal condition…”
Get full text

Guidance for the treatment of deep vein thrombosis and pulmonary embolism by Streiff, Michael B., Agnelli, Giancarlo, Connors, Jean M., Crowther, Mark, Eichinger, Sabine, Lopes, Renato, McBane, Robert D., Moll, Stephan, Ansell, Jack

“…This guidance document focuses on the diagnosis and treatment of venous thromboembolism (VTE). Efficient, cost effective diagnosis of VTE is facilitated by…”
Get full text

Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis by Hasan, Syed Shahzad, Radford, Sam, Kow, Chia Siang, Zaidi, Syed Tabish Razi

“…Many aspects of care such as management of hypercoagulable state in COVID-19 patients, especially those admitted to intensive care units is challenging in the…”
Get full text

Guidance for the evaluation and treatment of hereditary and acquired thrombophilia by Stevens, Scott M., Woller, Scott C., Bauer, Kenneth A., Kasthuri, Raj, Cushman, Mary, Streiff, Michael, Lim, Wendy, Douketis, James D.

“…Thrombophilias are hereditary and/or acquired conditions that predispose patients to thrombosis. Testing for thrombophilia is commonly performed in patients…”
Get full text

Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19 by Bautista-Vargas, Mario, Bonilla-Abadía, Fabio, Cañas, Carlos A.

“…In December 2019, a new and highly contagious infectious disease emerged in Wuhan, China. The etiologic agent was identified as a novel coronavirus, now known…”
Get full text

Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis by Mestre-Gómez, B., Lorente-Ramos, R. M., Rogado, J., Franco-Moreno, A., Obispo, B., Salazar-Chiriboga, D., Saez-Vaquero, T., Torres-Macho, J., Abad-Motos, A., Cortina-Camarero, C., Such-Diaz, A., Ruiz-Velasco, E., Churruca-Sarasqueta, J., Muñoz-Rivas, N.

“…Recent studies suggest that thrombotic complications are a common phenomenon in the novel SARS-CoV-2 infection. The main objective of our study is to assess…”
Get full text

Anticipating the long-term cardiovascular effects of COVID-19 by Becker, Richard C.

Get full text